Streetinsider.com's Hot Lunchtime Reads 9/7: (AMD) (LGND) (EXPR) (GILD)

September 7, 2016 12:04 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

The following is a list of notable articles to help get you through the lunch hour:
  • 1997 CMS Letter to Mylan (MYL) Shows Evidence of EpiPen Medicaid Rebate - Evecore ISI's Raffat -> Read this!

  • Moody's Lifts Outlook on Advanced Micro Devices (AMD) to Positive; Ratings Affirmed -> Read this!

  • Gilead Sciences (GILD) has internally discussed potential split up - Bloomberg, citing EVP -> Read this!

  • Stifel Expects Upside to Express' (EXPR) Cautious Outlook; Reiterates 'Buy' Rating -> Read this!

  • Roth Capital Bumps PT on Ligand Pharma (LGND) up to $151 Following Sparsentan Data; Affirms at 'Buy' -> Read this!



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Special Reports

Related Entities

Stifel, Roth Capital

Add Your Comment